In vitro studies have also shown that diosgenin can significantly ameliorate palmitic-acid-induced steatosis in LO2 cells by activating the AMPK/ACC/CPT-1A pathway and inhibiting the SREBP-1c/FAS pathway [144]. The gene discussed is FAS; the disease is steatosis.